ClinicalTrials.gg
Not yet recruitingNCT07434375Updated Feb 27, 2026

Speech Intervention Via Telepractice for Children With Repaired Cleft Palate

An interventional study of Speech therapy via teleprace and Face-to-face speech therapy in Cleft Palate Children and Speech Sound Disorder, sponsored by Texas Tech University Health Sciences Center. Not yet recruiting at 1 site in United States. Open to participants aged 5 Years to 11 Years. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by Texas Tech University Health Sciences Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
5 Years to 11 Years
Sex
All
01

Study summary

The goal of this interventional study is to see if online speech therapy works just as well as face-to-face speech therapy in children with cleft palate. The main purposes are:

To compare the speech accuracy of target sounds in words produced by children with cleft palate between online and face-to-face speech therapy.

To compare the gain in speech accuracy in sentences produced by children with cleft palate between online and face-to-face speech therapy.

To assess whether changes in speech intelligibility are perceived by parents. To explore what kinds of factors influence speech accuracy. To explore speech training accuracy and speech understandability training accuracy during speech therapy sessions in children with CP

Participants will participate in 30-minute speech intervention sessions twice a week for 10 weeks, either in-person or online.

02

Conditions studied

  • Cleft Palate Children
  • Speech Sound Disorder

Keywords

  • non-inferiority
  • telepractice
  • speech therapy
  • intervention
  • speech perception
  • speech production
  • cleft palate
  • children
03

In context

Speech Sound Disorder

46 studies on the registry are indexed under Speech Sound Disorder; 16 are open to participants now.

This study's planned enrollment of 64 is above the median of 40 across 39 interventional studies indexed under Speech Sound Disorder.

Browse Speech Sound Disorder studies →

Lead sponsor

Texas Tech University Health Sciences Center is the lead sponsor of 100 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Within the ages 5;0 and 11;11 (years; months) at enrollment and for enrollment duration
  • Having normal hearing based on a pure-tone hearing screening at 20 dB HL bilaterally at 500, 1000, 2000 and 4000Hz. Children with a history of hearing loss or children who currently are properly equipped with amplification will be included if they pass the hearing screening
  • Having typical nonverbal IQ, language, and socioemotional function as determined by a T-score with no more than -1.5 SD from the mean on Kauffman Brief Intelligence Test-2 (KBIT-2), receptive language of Clinical Evaluation Language Fundamentals-5 (CELF-5 Core Language), and Childhood Autism Rating Scale-2 (CARS-2)
  • Having a speech sound disorder as determined by a score ≤ 30th percentile on the Goldman-Fristoe Test of Articulation-3 (GFTA-3)
  • Demonstrate a cleft-related or a phonological error on at least one phoneme. For the sound, a cleft-related or a phonological error appears at word-initial phoneme on any two of the following tests; single words on GFTA-3, American English Phrase Samples (AEPS) and Sentence Sample (AESS) on the CAPS-A AM
  • Willing to comply with all study procedures and availability for the study duration.

Exclusion criteria

Exclusion Criteria:

  • Demonstrates a medically diagnosed sensory or neurological disorder based on parents' report
  • Presents with velopharyngeal insufficiency (VPI) due to structural anomalies or an oronasal fistula
  • English is not the primary language spoken at home. Bilingual children will not be excluded.
  • Children who do not demonstrate cleft speech characteristics.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Active comparator
    Telepractice Group

    Speech therapy delivered through telepractice modality

    Behavioral: Speech therapy via teleprace

  • Placebo comparator
    Face-to-Face Group

    Speech therapy delivered through face-to-face home health modality

    Behavioral: Face-to-face speech therapy

Interventions

  • BehavioralSpeech therapy via teleprace

    Children with cleft palate will participate in 30-minute speech therapy sessions twice a week for 10 weeks

  • BehavioralFace-to-face speech therapy

    Children with cleft palate will receive treatment maintaining the same frequency as the intervention group.

06

What researchers measure

Primary outcomes

  1. Change in percent correct for the target sound in words during post-treatment in Face-to-Face and Teletherapy interventions

    We will check speech accuracy using 16 test words or sounds for each target. To see how much someone improves, we will compare how many they say correctly after therapy to how many they said correctly before therapy. We calculate improvement by subtracting the number correct before therapy from the number correct after therapy, dividing that number by the total number of attempts, and then multiplying by 100 to get a percentage. Finally, we will compare the improvement percentages between the group that receives therapy online (telepractice) and the group that receives therapy in person (face-to-face).

    Time frame: Speech accuracy will be measured two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).

Secondary outcomes

  1. Change in percent correct for the target sound in sentences post-treatment in Face-to-Face and Teletherapy interventions

    Speech accuracy will be measured using 16 sentences for each target sound or speech goal. To calculate improvement, we will compare the number of sentences said correctly after therapy to the number said correctly before therapy. We subtract the "before" score from the "after" score, divide by the total number of attempts, and multiply by 100 to get a percentage improvement.

    Time frame: Speech accuracy will be measured two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).

Other outcomes

  1. Change in percent correct of perception of the target sound in words post-treatment in Face-to-Face and Teletherapy interventions

    Perceptual accuracy (how correctly a child hears specific sounds or words) will be measured using 24 words for the target sound. To calculate improvement, we will compare the number of words correctly identified as correct or incorrect after therapy to the number of words correctly identified before therapy. We subtract the "before" score from the "after" score, divide by the total number of attempts, and multiply by 100 to get a percentage improvement. Each child's overall improvement score will then be calculated by averaging their results across targets.

    Time frame: Accuray of perceiving speech sounds will be administered two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).

  2. Change in ratings of the Intelligibility in Context Scale post-treatment in Face-to-Face and Teletherapy interventions

    Functional outcomes (how well a child is understood in everyday situations) will be measured using the Intelligibility in Context Scale (ICS). This is a short questionnaire completed by parents about how easily their child is understood by different people. Improvement will be calculated by comparing the parent ratings after therapy to the ratings before therapy. The difference between these two scores will show how much progress was made. We will compare results between children who received therapy online (telepractice) and those who received therapy in person (face-to-face).

    Time frame: Intelligibility in Context Scale will be administered two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).

  3. Change in the F-ratio of the 's' and 'sh' consonants post-treatment in Face-to-Face and Teletherapy interventions

    We will measure how clearly children distinguish between the "s" sound (/s/) and the "sh" sound (/ʃ/) in different vowel contexts. To do this, children will repeat made-up words that follow a simple pattern (consonant-vowel-b), such as "soob." These words will include three different vowels: "ee" (i), "ah" (a), and "oo" (u). Each word will be said within a short sentence, such as "It's the soob again," during a repetition task. We will use a sound measurement called an F-ratio to compare the acoustic differences between the "s" and "sh" sounds for each vowel. This ratio is calculated by comparing the median frequency values of the two sounds within each vowel context. The overall F-ratio results for all participants combined will then be compared from before therapy (pre-test) to after therapy (post-test) to see whether the contrast between the sounds improved.

    Time frame: Acoustic values (F-ratio) will be assessed two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The NIH Public Access Policy requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to PubMed Central immediately upon acceptance for publication. This ensures that the public has access to the published results of NIH-funded research. In addition to disseminating data generated from this study in peer-reviewed journals and professional conferences, an integral part of this proposed research is the plan to share outcomes generated from this study with the public to facilitate clinical practice and research. We will share our data, knowledge, and technical outcomes gained through the completion of the proposed study in compliance with the NIH Data Sharing Policy. All data to be shared will be de-identified before sharing to ensure that participant's privacy is fully protected. Findings from this research have the potential to be immediately informative to speech-language pathologists, special education teachers, parents, and researchers workin

Supporting information: Clinical study report

Time frame: Available from February 2030 to February 2035.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07434375
Responsible party
Sue Ann Lee (Professor, Director of Cleft Palate and Craniofacial Anomaly Clinic, Texas Tech University Health Sciences Center) — Principal investigator
First posted
Feb 25, 2026
Start date
Mar 2, 2026 (estimated)
Primary completion
Jan 1, 2029 (estimated)
Completion
Jan 1, 2029 (estimated)
Last update
Feb 27, 2026

Study contacts

Chadley Copeland, MPA, MEd, CCRP
Contact
chadley.copeland@ttuhsc.edu
8067434752

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion